JPMorgan lowered the firm’s price target on Kimberly-Clark to $122 from $133 and keeps an Underweight rating on the shares. The analyst views the setup for the U.S. household and personal care stocks as “still challenging” into the Q3 reports. The firm anticipates sales deceleration on a sequential basis in Q3 virus Q2, saying most companies have lapped the pricing benefit. However, the “dislocation in valuation” presents an opportunity for quality names, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on KMB: